★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

Coloplast A/S vs Elekta AB (publ)

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Coloplast A/S

COLOB · Nasdaq Copenhagen

Market cap (USD)$14.2B
Gross margin (TTM)58.6%
Operating margin (TTM)26.5%
Net margin (TTM)7.5%
SectorHealthcare
IndustryMedical - Devices
CountryDK
Data as of2026-06-03
Moat score
76/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Coloplast A/S's moat claims, evidence, and risks.

View COLOB analysis

Elekta AB (publ)

EKTA B · NASDAQ Stockholm

Market cap (USD)$2.1B
Gross margin (TTM)37.4%
Operating margin (TTM)5.3%
Net margin (TTM)-3.1%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountrySE
Data as of2026-06-03
Moat score
70/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Elekta AB (publ)'s moat claims, evidence, and risks.

View EKTA B analysis

Comparison highlights

  • Moat score gap: Coloplast A/S leads (76 / 100 vs 70 / 100 for Elekta AB (publ)).
  • Segment focus: Coloplast A/S has 5 segments (35.5% in Ostomy Care); Elekta AB (publ) has 2 segments (55.8% in Solutions).
  • Moat breadth: Coloplast A/S has 7 moat types across 3 domains; Elekta AB (publ) has 7 across 3.

Primary market context

Coloplast A/S

Ostomy Care

Market

Ostomy care products (bags, plates, supporting products)

Geography

Global

Customer

Healthcare providers and distributors; end-users are ostomy patients

Role

Medical device manufacturer (disposable consumables)

Revenue share

35.5%

Elekta AB (publ)

Solutions

Market

Radiotherapy treatment delivery systems and oncology software solutions (linacs, MR-Linacs, stereotactic radiosurgery, treatment planning & oncology information systems)

Geography

Global

Customer

Hospitals, cancer centers, and clinics (often via public/central procurement)

Role

Medical device OEM + software/platform provider

Revenue share

55.8%

Side-by-side metrics

Coloplast A/S
Elekta AB (publ)
Ticker / Exchange
COLOB - Nasdaq Copenhagen
EKTA B - NASDAQ Stockholm
Market cap (USD)
$14.2B
$2.1B
Gross margin (TTM)
58.6%
37.4%
Operating margin (TTM)
26.5%
5.3%
Net margin (TTM)
7.5%
-3.1%
Sector
Healthcare
Healthcare
Industry
Medical - Devices
Medical - Instruments & Supplies
HQ country
DK
SE
Primary segment
Ostomy Care
Solutions
Market structure
Oligopoly
Oligopoly
Market share
35%-40% (reported)
40%-44% (reported)
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
76 / 100
70 / 100
Moat domains
Demand, Legal, Supply
Supply, Legal, Demand
Last update
2026-06-03
2026-06-03

Moat coverage

Shared moat types

Installed Base ConsumablesCompliance AdvantageService Field Network

Coloplast A/S strengths

Brand TrustTraining Org Change CostsReputation ReviewsDesign In Qualification

Elekta AB (publ) strengths

Capex Knowhow ScaleProcurement InertiaData Workflow LockinSwitching Costs General

Segment mix

Coloplast A/S segments

Full profile >

Ostomy Care

Oligopoly

35.5%

Continence Care

Oligopoly

32.5%

Voice & Respiratory Care

Oligopoly

8.4%

Wound & Tissue Repair

Competitive

13.4%

Interventional Urology

Oligopoly

10.3%

Elekta AB (publ) segments

Full profile >

Solutions

Oligopoly

55.8%

Service

Quasi-Monopoly

44.2%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.